Monthly Archives: April 2004
WASHINGTON, Apr 14, 2004 /PRNewswire via COMTEX/ — The Paralyzed Veterans of America (PVA), a national veterans’ service and Disability rights organization, in recognizing the accessibility of the redevelopment plans for Lower Manhattan, is proud to announce that Fredric Bell, FAIA, will be the recipient of the 2004 Barrier-Free America Award. PVA introduced the Barrier-Free America Award in 2001 to recognize individual leadership in making America more accessible for all Americans.
Over the past several decades, I have observed remarkable progress in our understanding of spinal cord injury (SCI), a disorder once considered so intractable that its repair was described as the Holy Grail of neurological research. As demonstrated by innovative therapies being developed throughout the world, this Grail is increasingly within our grasp. So many promising procedures are in the developmental pipeline, it is difficult to keep track of them all.
DETROIT (AP) – The Rehabilitation Institute of Michigan will open a center this summer offering new therapies to help spinal cord injury patients regain some sensation and movement after years of paralysis.
The center, unlike any in the United States, also will evaluate hundreds of spinal cord patients for two experimental operations abroad and oversee their rehabilitation in Detroit.
Can a machine read a person’s mind? A medical device company is about to find out.
The company, Cyberkinetics Inc., plans to implant a tiny chip in the brains of five paralyzed people in an effort to enable them to operate a computer by thought alone.
Potential returns may be years away, and society’s moral concerns make investors nervous
SEATTLE — Whoever learns to control embryonic stem cells that can morph into healthy human cells could be standing on a gold mine: Four million Americans have damaged brain cells from Alzheimer’s, and a million people each year suffer tissue damage from heart attacks.
NIL-A is a neuroimmunophilin that was developed by Guilford and Amgen for Parkinson’s disease . A second generation product, NIL-A succeeds an earlier immunophilin product called GPI-1046. Preclinical development of GPI-1046 itself appears to have been suspended . Data from efficacy and pharmacokinetic studies with NIL-A were presented at the Acute Neuronal Injury: New Therapeutic Opportunities meeting in August of 1998, Las Vegas, USA. The compound apparently possesses 50% oral bioavailability, and approximately 25 fold greater efficacy compared with GPI 1046, as well as a superior half life and absorption profile.
Their stories are amazing: Cardiac patients who recover rapidly after their own stem cells are implanted into their hearts; people with spinal cord injuries who have some feeling restored in their bodies.
“Miracle Cell” showcases some of the doctors and patients involved in experimental trials in regenerative medicine, which aims to harness the natural ability of the body to renew and heal itself.
Inside UVic’s Motor control research lab, investigations into such commonplace activities as walking is revealing secrets about the nervous system that may one day improve motor function in people who have suffered stroke or spinal cord injury.
Directing this research is Dr. Paul Zehr of UVic’s school of physical education, armed with nearly $1 million in funding and a desire to advance neurotrauma research at UVic.
Stem-cell surgery shows promise
Some words spark debate every time they are spoken, few more surely than “stem cells.” Many ordinary people who smile on the possible outcome of stem-cell research, namely the Regeneration of failed or injured body parts, frown on obtaining stem cells from embryos grown in a lab.
Employees from Headquarters, TRADOC visit the local VA Hospital spinal cord unit for an afternoon of games, fun
First-time visitors to the Hampton VA Medical Center’s Spinal Cord Injury Unit rarely know what to expect. So, they brace themselves for the worst: that unmistakable hospital smell, dark corridors, and desperate faces.